PALONOSETRON HYDROCHLORIDE | N021372 | HELSINN HEALTHCARE SA
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Helsinn Healthcare S.A. et al v. Baxter Healthcare Corporation 2 patentsANDA 206916palonosetron hydrochloride | D. Del. | 2018-10-25 | Terminated 2019-08-05 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Exela Pharma Sciences FDA-2018-P-1197 Exela Pharma Sciences filed this petition requesting that the FDA assign a therapeutic equivalence code of "AP" in the Orange Book for Exela's Palonosetron Hydrochloride Injection 0.125 mg/mL (2 mL vial) approved under NDA 207963, claiming the product is pharmaceutically and therapeutically equivale | Other | 2018-03-20 | Denied | Exela Pharma Sciences |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.